A. M. Liberati

Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

Kirsten Fischer, Othman Al‐Sawaf, Jasmin Bahlo et al. · New England Journal of Medicine · 2019 · 852 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Wolfgang Knauf, Toshko Lissichkov, Ali Aldaoud et al. · Journal of Clinical Oncology · 2009 · 439 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial

Haifa Kathrin Al‐Ali, Philipp le Coutre, Cornelius F. Waller et al. · Haematologica · 2016 · 158 citations · Full text

Medicine, Hematology, Pharmacology +15

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase <scp>III</scp> trial

Wolfgang Knauf, Toshko Lissitchkov, Ali Aldaoud et al. · British Journal of Haematology · 2012 · 107 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study

Massimo Offidani, Laura Corvatta, Laura Maracci et al. · Blood Cancer Journal · 2013 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14